Protagonist Therapeutics, Inc — All Filings
657 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001104659-21-117017 | Sep 17, 2021 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-21-107818 | Aug 19, 2021 | Aug 17, 2021 |
| 8-K | FORM 8-K | 0001104659-21-102543 | Aug 10, 2021 | Aug 4, 2021 |
| 10-Q | 10-Q | 0001558370-21-010244 | Aug 4, 2021 | Jun 30, 2021 |
| 8-K | FORM 8-K | 0001104659-21-100078 | Aug 4, 2021 | — |
| 8-K | FORM 8-K | 0001104659-21-096941 | Jul 28, 2021 | Jul 27, 2021 |
| 8-K | FORM 8-K | 0001104659-21-082678 | Jun 17, 2021 | Jun 15, 2021 |
| 424B5 | 424B5 | 0001104659-21-082601 | Jun 17, 2021 | — |
| 424B5 | 424B5 | 0001104659-21-080855 | Jun 14, 2021 | — |
| 8-K | FORM 8-K | 0001104659-21-080820 | Jun 14, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-036664 | May 28, 2021 | May 27, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-036663 | May 28, 2021 | May 27, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-036662 | May 28, 2021 | May 27, 2021 |
| 8-K | FORM 8-K | 0001104659-21-074317 | May 28, 2021 | May 27, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-036667 | May 28, 2021 | May 27, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-036670 | May 28, 2021 | May 27, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-036680 | May 28, 2021 | May 27, 2021 |
| 10-Q | 10-Q | 0001558370-21-005733 | May 4, 2021 | Mar 31, 2021 |
| 8-K | FORM 8-K | 0001104659-21-060967 | May 4, 2021 | — |
| DEFA14A | DEFA14A | 0001104659-21-050207 | Apr 14, 2021 | — |
| DEF 14A | DEF 14A | 0001104659-21-050202 | Apr 14, 2021 | May 27, 2021 |
| 8-K | FORM 8-K | 0001104659-21-034431 | Mar 10, 2021 | — |
| S-8 | FORM S-8 | 0001104659-21-034494 | Mar 10, 2021 | — |
| 10-K | 10-K | 0001558370-21-002715 | Mar 10, 2021 | Dec 31, 2020 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-014981 | Feb 26, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-014984 | Feb 26, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-014976 | Feb 26, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-014973 | Feb 26, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-014967 | Feb 26, 2021 | — |
| SC 13G | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-21-001026 | Feb 17, 2021 | — |
| SC 13G | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-21-000931 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 4 TO THE SCHEDULE 13G | 0000921895-21-000409 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 3 | 0001214659-21-001721 | Feb 16, 2021 | — |
| SC 13G/A | — | 0001493152-21-003507 | Feb 12, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-010401 | Feb 12, 2021 | Feb 10, 2021 |
| SC 13G/A | PROTAGONIST THERAPEUTICS, INC. | 0000902664-21-001142 | Feb 11, 2021 | — |
| SC 13G/A | — | 0000315066-21-001243 | Feb 8, 2021 | — |
| SC 13G | — | 0000834237-21-006869 | Feb 2, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-004570 | Jan 20, 2021 | Jan 19, 2021 |
| 424B5 | 424B5 | 0001104659-20-134892 | Dec 14, 2020 | — |
| 8-K | FORM 8-K | 0001104659-20-134457 | Dec 11, 2020 | Dec 10, 2020 |
| S-3ASR | S-3ASR | 0001104659-20-133938 | Dec 10, 2020 | — |
| 424B5 | 424B5 | 0001104659-20-133946 | Dec 10, 2020 | — |
| 10-Q | 10-Q | 0001558370-20-012597 | Nov 4, 2020 | Sep 30, 2020 |
| 8-K | FORM 8-K | 0001104659-20-121408 | Nov 4, 2020 | — |
| 8-K/A | FORM 8-K/A | 0001104659-20-111763 | Oct 2, 2020 | Aug 11, 2020 |
| 8-K | FORM 8-K | 0001104659-20-104437 | Sep 11, 2020 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-20-047233 | Aug 18, 2020 | Aug 12, 2020 |
| 4 | FORM 4 SUBMISSION | 0001209191-20-047246 | Aug 18, 2020 | Aug 17, 2020 |
| 8-K | FORM 8-K | 0001104659-20-094719 | Aug 13, 2020 | Aug 11, 2020 |